EP3397218A1 - Pansement - Google Patents

Pansement

Info

Publication number
EP3397218A1
EP3397218A1 EP16819326.6A EP16819326A EP3397218A1 EP 3397218 A1 EP3397218 A1 EP 3397218A1 EP 16819326 A EP16819326 A EP 16819326A EP 3397218 A1 EP3397218 A1 EP 3397218A1
Authority
EP
European Patent Office
Prior art keywords
wound
layer
pad
wound pad
folded
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP16819326.6A
Other languages
German (de)
English (en)
Inventor
Markus Rothmaier
Fabian VOLKART
Guillaume Bugnard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
IVF Hartmann AG
Original Assignee
IVF Hartmann AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by IVF Hartmann AG filed Critical IVF Hartmann AG
Publication of EP3397218A1 publication Critical patent/EP3397218A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/00051—Accessories for dressings
    • A61F13/00063—Accessories for dressings comprising medicaments or additives, e.g. odor control, PH control, debriding, antimicrobic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/00051—Accessories for dressings
    • A61F13/00072—Packaging of dressings
    • A61F13/00076—Packaging of adhesive dressings
    • A61F13/0008—Packaging of adhesive dressings having means for facilitating the removal of the packaging and release liner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/00051—Accessories for dressings
    • A61F13/00085—Accessories for dressings having means for facilitating the application on the skin, e.g. single hand handling facilities
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/02—Adhesive bandages or dressings
    • A61F13/0203—Adhesive bandages or dressings with fluid retention members
    • A61F13/0206—Adhesive bandages or dressings with fluid retention members with absorbent fibrous layers, e.g. woven or non-woven absorbent pads or island dressings
    • A61F13/0209—Adhesive bandages or dressings with fluid retention members with absorbent fibrous layers, e.g. woven or non-woven absorbent pads or island dressings comprising superabsorbent material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/02—Adhesive bandages or dressings
    • A61F13/023—Adhesive bandages or dressings wound covering film layers without a fluid retention layer
    • A61F13/0236—Adhesive bandages or dressings wound covering film layers without a fluid retention layer characterised by the application/handling support layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F2013/00361—Plasters
    • A61F2013/00795—Plasters special helping devices
    • A61F2013/00817—Plasters special helping devices handles or handling tabs
    • A61F2013/00821—Plasters special helping devices handles or handling tabs with hinge means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F2013/00361—Plasters
    • A61F2013/00897—Plasters package for individual plaster

Definitions

  • the invention relates to a wound dressing for wound treatment, in particular in a moist or moist wet environment, with a wound pad, wherein the wound pad manufacturer with a salt-containing aqueous solution, in particular
  • Ringer solution applied and can be included in an outer packaging, wherein the wound pad
  • Such a wound dressing for wound treatment in a moist or wet-moist environment is known from WO 2011/141454 A1 or EP 0 594 034 B1 of the Applicant.
  • This is a pillow-like or compress-like wound dressing which can be applied to a wound or can also be used to stamp out deep wounds.
  • the Wound pad is designed here as a suction / rinsing body and is supplied by the manufacturer with a salt-containing aqueous solution, which swell contained in the absorbent / rinsing superabsorbent material and into a
  • Decubital ulceration or ulcus cruris is preferred.
  • the present invention is based on the object, the wound dressing from the outside against a wound surrounding the wound
  • Circumferentially encloses the circumferential direction, and that the edge-side adhesive coating having areas of the layer projecting beyond the wound pad manufacturer for delivery to the consumer by folding at least four fold lines on the side facing away from the wound
  • Wound pads are folded so that the fold lines enclose the wound pad in the circumferential direction, and that the folded areas are covered by the manufacturer side of at least one removable protective layer which is parallel to the plane.
  • the wound pad is thus surrounded in the circumferential direction by an adhesive edge area.
  • Edge region is then folded over the at least four fold lines on the wound or body side facing away from the wound dressing.
  • the removable protective layer is then provided which overhangs and thus covers the folded, adhesive-coated areas.
  • the wound pad is not folded but extends in a plane.
  • the removable protective layer is also in this plane or extending parallel thereto.
  • the wound dressing is fixed to the patient by means of the adhesive regions folded on the side facing the side of the wound, which are produced by the manufacturer and still when removing the wound dressing from an outer packaging.
  • the wound dressing is so on the patient
  • the user or a caregiver can replace the at least one protective layer. Because the protective layer releasably adheres to adhesive coated folded portions of said layer radially overlying the wound pad, release of the protective layer may be used simultaneously to fold back at least one of the folded portions toward the user's skin surface. In this way, the wound dressing is then once attached to the user liable, so they do not
  • Wound dressing is fixed on the patient. It will
  • the wound dressing is approximately rectangular or square, and that four, in particular rounded, corner regions project beyond the wound pad and at the marginal edge
  • Adhesive coating layer are provided and that the four corner regions are folded over each fold line on the sore side facing away from the wound pad and that four areas of the layer between the corner regions are in turn folded over a respective fold line on the side facing away from the wound pad, so that they previously folded corner areas at least partially
  • the wound dressing is again positioned on the patient, covering the wound. Then the
  • a first folded portion is folded against the skin surface of the user, as described above. After gently pressing this adhesive area against the skin surface, the wound dressing is positioned and the remaining areas can be folded back accordingly. The four remain in the course of production as the first on the
  • Corner areas are finally after radially outward in the direction of the skin surface of the
  • Adhesive coating layer are each covered with a peelable and corresponding to the corner regions extending peel sheet, so that the areas folded on it do not adhere.
  • the fact that the corner areas are covered by the manufacturer with a peelable peel film, can be prevented according to the invention that the subsequent folded on the side facing away from the wound on the previously folded corner areas too strong and complicate a detachment in the course of applying the wound dressing on the patient.
  • the at least one detachable protective layer can also have two or more separate protective layer sections which can overlap one another and, in particular, can be detached independently of one another such that, upon detachment of the protective layer sections, two opposite folded-over regions are folded back around their fold line and the two other folded areas essentially
  • the fold lines are preferably parallel to each other, and that the folded areas are covered by a removable first protective layer, and that two second opposite each other with respect to the wound pad
  • Areas of the layer projecting beyond the wound pad and having the edge-side adhesive coating are each folded around the wound pad on the side of the wound pad which is tangent to the wound pad, the fold lines preferably being parallel to one another, and the folded-over second areas being overlapped by a detachable second protective layer , In this embodiment, therefore, is a separate
  • the wound dressing is again positioned and after detachment of the uppermost second
  • Protective layer can fold back the second opposite edge areas, ie in the direction of the
  • the two first and the two second fold lines are substantially orthogonal to each other.
  • the wound dressing is used in a moist or wet-moist environment and this is already supplied by the manufacturer with a salt-containing aqueous solution, it is advantageous if the marginal
  • Adhesive coating manufacturer is protected from direct contact with the aqueous solution. This can be achieved, for example, by coating those areas of the layer projecting beyond the wound padding on the edge side of the adhesive layer with a water-impermeable layer on the manufacturer side. This layer may also be the one mentioned above
  • detachable protective layer act.
  • a fluid access could still be in the plane of the
  • edge-side adhesive coating on the projecting beyond the wound pad layer of an inner and an outer circumferentially continuous and self-contained, in particular made of silicone bead is bounded radially inward and radially outward with the bead slightly raised from the layer on its sore side. This bead can then act as a radial seal between the the edge-side adhesive coating bearing layer and the protective layer act.
  • the layer having the edge-side adhesive coating projecting beyond the wound pad on the
  • a receiving space for the adhesive is created, which can be relatively easily and effectively sealed by a liquid-tight protective layer.
  • the wound pad is formed by a particular fiber fleece-based suction / rinsing body.
  • a foam-based suction / rinsing body would be conceivable.
  • the wound pad comprises a covering forming the outer visible sides of the wound dressing. It can then be formed with further additives, such as superabsorbent particulate materials.
  • the wound pad can be held together in a compact manner as a flat layer.
  • the wrapping on the wound-facing side of the wound dressing comprises a layer of a textile sheet material, in particular of a knitted fabric, knitted fabric or fabric. This will be a
  • Fluid exchange between the wound pad and the Wound room allows, as the aforementioned textile
  • Nonwoven layer comprises, which forms the wound-facing outer visible side of the wound dressing, and that on the
  • the nonwoven layer, the Kunststofffmm slaughter, the wound pad and the layer of textile sheet material are not areally connected to each other, but with their flat sides loosely and slidably against each other, wherein the nonwoven layer, the Kunststofffmm slaughter, the wound pad and the layer of textile sheet material are not areally connected to each other, but with their flat sides loosely and slidably against each other, wherein the nonwoven layer, the Kunststofffmm slaughter, the wound pad and the layer of textile sheet material are not areally connected to each other, but with their flat sides loosely and slidably against each other, wherein the nonwoven layer, the
  • Kunststofffilm Mrs the wound pad and the layer of textile sheet material along only one peripheral edge of the wound pad by a joint connection, in particular a Ultraschall hydrogeraum, are interconnected.
  • wound-facing outer visible side of the wound dressing does not have the same effect as in the case of the previously known product of an artificial textile film layer, but of a
  • Nonwoven layer is formed, the tactile and haptic graspability of the wound dressing, also by means of instruments, improved because the nonwoven layer is less slippery than a Kunststofffilm für, but also in the wet state can be described as handy. Furthermore, the appearance and feel, especially in contact with the gloves of the nursing staff and with the body surface of the patient, is improved. Further it proves to be advantageous that the flexibility and the drapability of the wound dressing according to the invention is improved. It was surprisingly found that the Kunststofffmm Mrs not arranged outside but on the wound facing side of the nonwoven layer does not hinder the flexibility and drapability of the wound dressing, which is also attributed to the fact that the layers are not connected to each other but only along the edge of the wound pad, so that they according to the invention with their flat sides only loose and
  • Adhesive coating layer forms. According to this inventive concept, therefore, the envelope of the wound pad, in particular of the suction / rinsing body, or a layer of this envelope at the same time for the formation of the over
  • Tissue pad protruding layer used, which receives the edge-side adhesive coating.
  • the mentioned visible non-woven fiber layer can be made of thermoplastic fiber material, in particular
  • Polyolefin in particular of polypropylene, be formed.
  • the wound-facing side of the wound dressing is preferably 15-100 g / m 2 , preferably 20-60 g / m 2 , particularly preferably 25- 40 g / m 2 .
  • the density of the fiber fleece layer on the side facing away from the wound Wound dressing 10-1000 kg / m, preferably 50-250 kg / m,
  • thermoplastic material in particular of polyolefin, in particular of polypropylene, is formed.
  • the wound pad is designed as a nonwoven based absorbent / rinsing body and cellulosic fibers, in particular a mixture of cellulosic fibers and thermoplastic fibers, in particular polyolefin fibers, in particular polypropylene fibers or polypropylene / polyethylene fibers comprises.
  • the basis weight of the fiber portion of the suction / Spül stresses advantageously 20 to 500 g / m 2, preferably 30-300 g / m 2, more preferably 30-200 g / m 2, especially 30-150 g / m 2.
  • Fiber content of the suction / Spül stresses 20-500 kg / m 3 preferably 30-300 kg / m 3 , more preferably 50-200 kg / m 3 .
  • the layer of textile sheet material is formed from a thermoplastic material, in particular from polyolefin, in particular from polypropylene. Furthermore, it proves to be advantageous if an atraumatic-acting coating is provided partially and structured on the wound-facing side of the wound pad or the absorbent / rinsing body.
  • Degree of coverage of the partially and structured applied atraumatic coating is 20-70%, in particular 25-50%, in particular 30-40%. It proves to be more advantageous if the partially and structured applied atraumatic coating.
  • Coating strip is formed.
  • the strips can be linearly extended. They are lost
  • the width of a strip is advantageously 1 to 3 mm.
  • the distance of the strips from each other is
  • Wound dressing is designed such that the superabsorbent material absorbed in the wound pad is anionic and has negative groups, and that the aqueous solution comprises a substance with antimicrobial activity, which is silver cations, biguanide or biguanide derivatives, preferably polyhexamethylene biguanide (polyhexanide, PHMB) , Polyguanidines, N-octyl-1- [10- (4-octyliminopyridin-1-yl) decyl] pyridin-4-imine (octenidine), quaternary
  • a substance with antimicrobial activity which is silver cations, biguanide or biguanide derivatives, preferably polyhexamethylene biguanide (polyhexanide, PHMB) , Polyguanidines, N-octyl-1- [10- (4-octyliminopyridin-1-yl) decyl] pyridin-4-imine (octen
  • superabsorbent material within the suction / irrigation body is preferably 30-150 g / m, in particular 50-100 g / m 2 , in particular 60-80 g / m 2 .
  • Figure 1 is a schematic sectional view of a
  • wound dressing according to the invention before the folding over of regions of a layer projecting beyond the wound pad, a layer having adhesive coating on the edge;
  • Figure 2 is a view of the wound dressing with a view of the
  • FIGS. 3 a-g illustrate the manufacturer-side folding over of the regions of the layer projecting beyond the wound pad in the case of a first embodiment of the wound dressing according to the invention
  • FIGS. 4 a - c illustrate the manufacturer-side folding over of the regions of the layer projecting beyond the wound pad in the case of a second embodiment of the wound dressing according to the invention
  • FIG. 1 shows in section a wound dressing 2. It comprises a wound pad 2 in the form of a suction / rinsing body 4 based on nonwoven fabric.
  • this nonwoven base is a preferred blend of airlaid cellulosic fibers (pulp) and polypropylene fibers or polypropylene / polyethylene fibers.
  • This fiber mixture is exemplified by superabsorbent polymer materials (SAP) in particle form or in fiber form as homogeneously as possible
  • the SAP content of the total mass of the suction / Spül stresses 4 is preferably 40 - 50 wt .-%.
  • the average particle size of the SAP particles is
  • the suction / rinsing 4 is an example of a
  • the wound-facing enveloping layer 8 is preferably a layer 9 of a textile flat material, such as a knitted fabric, preferably of polypropylene, wherein a woven or knitted fabric would also be conceivable in an advantageous manner, ie a covering layer of filaments or filaments with textile bonding, which allows a good fluid exchange between the suction / rinsing body 4 and the wound environment.
  • the one wound-away cover layer 10a is a
  • Nonwoven fabric layer 12 preferably made of polypropylene, which forms a visible side facing away from the wound site 14 of the wound dressing 2.
  • the second sore layer 10b facing away from the sore is formed by a liquid-impermeable plastic film layer 16 immediately below the nonwoven layer 12, so on the sore side of the
  • Nonwoven fabric layer 12 between the nonwoven fabric layer 12 and the suction / rinsing body 4 is arranged.
  • Components of the wound dressing are connected.
  • the layers of the wound dressing are fed as endless sheet materials in each case in a machine direction and arranged one above the other. So these are the ones
  • Nonwoven fabric layer 12 the Kunststofffmm slaughter 16 a nonwoven fabric layer with superabsorbent
  • a joining compound covering all layers is produced, preferably in the form of an ultrasonic welding connection.
  • the width of the joint transverse to its longitudinal extent is preferably very small, so that it is barely perceptible on the finished product.
  • the wound-facing coating layer 8 and the wound-facing coating layers 10a, b are separated from one another stretched so that the impression of a very flat marginal rounded wound pad arises.
  • wound-facing envelope layer 8 a partially and
  • Coating 22 is provided.
  • This coating 22 is preferably a silicone coating, wherein the
  • Coating in the case exemplified is formed by a plurality of relatively thin strips 24 or lines or inseiform areas which are separated from each other by non-coated areas. In these uncoated areas is the sore
  • Envelope layer material remains open three-dimensionally and provides or retains less resistance to fluid passage in both directions over the useful life of the wound dressing.
  • the nonwoven base of the absorbent / rinsing body 4 consists of 33 g / m 2 cellulose fibers (pulp), 11 g / m 2 polypropylene / polyethylene fibers as binder fibers. 70 g / m 2 of the abovementioned superabsorbent polymer materials (SAP) are mixed homogeneously with this fiber mixture.
  • the mixture thus obtained (nonwoven base + SAP), which forms the suction / rinsing body 4 can also from a cellulosic tissue layer, in particular a basis weight of exemplarily 17 g / m 2 on each side, be surrounded (not shown in the figure); however, this is not mandatory.
  • the wound dressing can be designed, for example, round or rectangular, with an exemplary dimension of the wound pad 2 or of the suction / rinsing body 4 of 5-10 cm.
  • edge adhesive coating 32 is provided, which projects beyond the wound pad 2 radially outwardly
  • the one projecting radially beyond the wound pad 2 is outwardly projecting
  • all enveloping layers 8, 10a, 10b or only individual layers can be used to form the layer 34 projecting beyond the wound pad 2.
  • Wound-facing side 14 of the wound dressing 1 folded over and there overlaid with a removable protective layer.
  • FIG. 2 illustrates the partial and structured application of the atraumatic coating 22, which is applied here in the form of strips 24.
  • Figure 3a shows the wound dressing 1 with a view of the
  • edge-side adhesive coating 32 of the layer 34 completely surrounds the wound pad 2 in the circumferential direction 30. It can be seen further four corner areas 38 with a respectively indicated fold line 40. These corner portions 38 are exemplary but not necessarily covered with a peelable peel film 42. The corner regions 38 are then folded over by the manufacturer on the side facing away from the wound (FIG. 3C).
  • FIG. 3d shows the view of the wound dressing folded in this way with a view of the side facing away from the sore. It can be seen that the adhesive coating of the corner regions 38 also shows
  • Adhesive coating 32 turned upwards (Fig 3e). Then, a removable protective layer 48 is applied, which is formed by way of example of two separate detachable sections.
  • the wound dressing with its wound-facing side 20 is placed on the wound, whereby the wound pad 20 should completely cover the wound.
  • the portions of the protective layer 48 are detached with two hands simultaneously or sequentially in the direction of the arrows 50, whereby their associated transversely to the arrows 50 extended folded portions 44 are folded back toward the wound facing side 8 and then with their adhesive coating 32 on Patients can adhere.
  • the two further regions 44 are folded back outward about their respective fold line and also attached to the patient.
  • the respective peel sheets 42 are removed from the folded-over corner regions 38 and then these corner regions 38 are also folded back outwards, so that the wound dressing then with its in the circumferential direction 30 continuously passing edge-side adhesive coating 32 on
  • FIGS. 4a-c show a further embodiment of the wound dressing according to the invention, in which corner regions are not folded over separately.
  • Adhesive coating 32 and over the wound pad 2 protruding layer 34 comprises two first opposing portions 60. These first portions 60 are about a respective fold line 62 on the
  • Adhesive coating 32 of the folded-over first regions 60, a first protective layer 64 is applied (FIG. 4b).
  • Areas 66 of the layer 34 are folded over respective fold lines 68 on the side facing away from the sore 14, and a second removable protective layer 70 is applied, which corresponds to the planar extent of the configuration thus obtained and the adhesive coating 32 of the second folded regions 66 overlaps ( Figure 4c).
  • the wound dressing with its wound pad 2 is positioned on the patient, covering the wound. Then the second
  • Protective layer 70 detached and with the fingers of the same or the other hand, the second portions 66 in Direction of the patient folded so that they can adhere to the patient with their adhesive coating 32. Thereafter, the then-apparent first protective layer 64 is peeled off, and the first regions 60 are folded in the direction of the skin surface of the patient, so that the wound dressing with a continuous in the circumferential direction of the wound pad 2 adhesive coating 32 at the skin surface surrounding the wound of the patient.
  • FIG. 5 shows schematic sectional views of a
  • Beads 80 thus form a receiving space for the
  • Adhesive coating 32 By means of a removable protective layer 82 that covers this receiving space, the adhesive can be protected from the effects of moisture. If this wound dressing is folded by the manufacturer according to the invention, it may prove advantageous that the
  • wound-facing side of the wound dressing is applied and in particular by the protective layers 48, 64, 70 is formed.
  • the layer 34 projecting beyond the wound pad 2 has several deep-drawn layers Grooves 84 which receive the adhesive coating 32.
  • the adhesive can be protected from moisture by a removable protective layer 82.

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Materials For Medical Uses (AREA)

Abstract

L'invention concerne un pansement (1) pour le traitement des plaies, en particulier en milieu humide ou mouillé, comprenant une compresse (2), qui peut être exposée à une solution aqueuse saline, notamment une solution de Ringer, chez le fabricant, et qui est conditionné chez le fabricant aux fins de la distribution au consommateur en une configuration non pliée formant un plan. Ledit pansement est caractérisé en ce qu'un revêtement adhésif (32) marginal est prévu sur une couche (34) dépassant de la compresse (2) dans une direction de la périphérie (30) tout autour de la compresse (2) et entoure en continu la compresse (2) dans la direction de la périphérie (30), et en ce que les régions (36) de la couche (34) dépassant de la compresse (2) qui présentent le revêtement adhésif (32) marginal sont pliées chez le fabricant pour la distribution au consommateur par pliages sur au moins quatre lignes de pliage (46, 62, 68) du côté de la compresse opposé à la plaie de telle manière que les lignes de pliage (46, 62, 68) entourent la compresse (2) dans la direction de la périphérie (30) et en ce que les régions pliées (36) sont recouvertes chez le fabricant d'au moins une couche protectrice amovible (48, 64, 70) parallèle au plan.
EP16819326.6A 2015-12-29 2016-12-27 Pansement Withdrawn EP3397218A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102015226790.3A DE102015226790A1 (de) 2015-12-29 2015-12-29 Wundauflage
PCT/EP2016/082701 WO2017114825A1 (fr) 2015-12-29 2016-12-27 Pansement

Publications (1)

Publication Number Publication Date
EP3397218A1 true EP3397218A1 (fr) 2018-11-07

Family

ID=57629592

Family Applications (1)

Application Number Title Priority Date Filing Date
EP16819326.6A Withdrawn EP3397218A1 (fr) 2015-12-29 2016-12-27 Pansement

Country Status (3)

Country Link
EP (1) EP3397218A1 (fr)
DE (1) DE102015226790A1 (fr)
WO (1) WO2017114825A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3636233B1 (fr) 2018-10-12 2023-06-07 IVF Hartmann AG Pansement humide à bord de collage

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4781293A (en) 1987-12-23 1988-11-01 Pfizer Hospital Products Group, Inc. One step dressing delivery system
DK0594034T3 (da) 1992-10-22 1997-07-07 Ivf Internationale Verbandstof Plastisk deformerbart kompres.
US5772623A (en) * 1995-08-10 1998-06-30 Conte; Stephen Bandage having a tab portion for facilitating easy removal from the skin
GB2369997B (en) * 2000-12-12 2004-08-11 Johnson & Johnson Medical Ltd Dressings for the treatment of exuding wounds
JP4054204B2 (ja) * 2002-03-08 2008-02-27 ダイヤ製薬株式会社 携帯型パッド材
DE10345665B4 (de) * 2003-01-16 2012-04-12 Drita Ivezaj Wundpflaster
EP1462075A1 (fr) 2003-03-24 2004-09-29 IVF Hartmann AG Elément de fixation d'un pansement sur la peau
GB2421188A (en) 2004-12-14 2006-06-21 Pearson Matthews Improved adhesive dressing
DE102007029796A1 (de) 2007-06-27 2009-01-08 Paul Hartmann Ag Wundverband
DE202009015670U1 (de) * 2009-11-30 2011-04-14 Mcairlaid's Vliesstoffe Gmbh & Co. Kg Absorptionskörper zur Auflage auf Wunden
DE102010020050A1 (de) 2010-05-11 2011-11-17 Ivf Hartmann Ag Wundauflage
DE202010008025U1 (de) * 2010-07-09 2011-10-27 Mcairlaid's Vliesstoffe Gmbh & Co. Kg Absorptionskörper zur Auflage auf Wunden

Also Published As

Publication number Publication date
WO2017114825A1 (fr) 2017-07-06
DE102015226790A1 (de) 2017-06-29

Similar Documents

Publication Publication Date Title
EP3636233B1 (fr) Pansement humide à bord de collage
EP2004116B1 (fr) Pansement primaire
DE60223145T2 (de) Wundverbände und wundbehandlungszusammensetzungen
EP0012295B1 (fr) Serviette hygiénique
DE69727248T2 (de) Entnahmesystem eines medizinischen klebeverbandes und methode
EP3011978B1 (fr) Matériau pour pansement et son procédé de fabrication
EP2424477B1 (fr) Feuille pour pansement
WO2012146656A1 (fr) Article pour le soin des plaies comportant un motif d'incisions et/ou de gaufrages
DE102010020050A1 (de) Wundauflage
EP3277239B1 (fr) Pansement pour le traitement d'une plaie en milieu humide ou mouillé
DE4305662C2 (de) Verpackungsbeutel
DE202010008025U1 (de) Absorptionskörper zur Auflage auf Wunden
DE102005009635A1 (de) Folienverband mit Applikationshilfe
EP2338449A1 (fr) Corps d'absorption pour l'application sur des plaies
EP3400920B1 (fr) Pansement de traitement d'une plaie
WO2017114825A1 (fr) Pansement
EP1514678A1 (fr) Structure non tissée multilcouche
DE60018977T2 (de) Damenbinde mit einem ausschnitt in der abziehfolie
EP1640290A1 (fr) Coussin absorbant pour produits de viande et de volaille
EP4205711B1 (fr) Pansement respirant auto-adhésif pour plaies à exsudat fort
WO2011086063A2 (fr) Nouvelles technologies pour l'utilisation dans des installations vulnéraires à polymères super-absorbants
WO2015185223A1 (fr) Couvre-doigt jetable pourvu d'un produit de soins pour chaussures
AT17688U1 (de) Verpackungseinheit von Hygieneartikeln
EP2747794A1 (fr) Garniture conçue pour un article d'hygiène ou de soin
DE202012102259U1 (de) Bezug für einen Hygiene- oder Pflegeartikel

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: UNKNOWN

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20180607

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20220216

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20220628